Double Bond Pharmaceutical International AB Logo

Double Bond Pharmaceutical International AB

DBP B | SPGR

Overview

Corporate Details

ISIN(s):
SE0007185517 (+1 more)
LEI:
254900U1MWE2YSPREX74
Country:
Sweden
Address:
Virdings Alle 32B, 754 50 Uppsala
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Double Bond Pharmaceutical International AB is a pharmaceutical company specializing in the redevelopment of established drugs to improve their safety and efficacy. The company's strategy centers on applying its proprietary drug delivery technologies to create new formulations of proven medications. Its key platforms include BeloGal®, a biomimetic encapsulation system that enables targeted delivery of active ingredients to specific organs, and an innovative hydrogel for localized treatment. This approach aims to enhance therapeutic effects while minimizing systemic toxicity. The company's pipeline focuses on areas with significant unmet medical needs, such as oncology and infectious diseases. Lead candidates include SI-053 for glioblastoma (brain cancer), SA-033 for liver cancer, and Belopenem for pneumonia.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Double Bond Pharmaceutical International AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Double Bond Pharmaceutical International AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Double Bond Pharmaceutical International AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Newbury Pharmaceuticals AB Logo
Markets specialty prescription drugs in Scandinavia for oncology, rare diseases, and neurology.
Sweden NEWBRY
New Nordic Healthbrands AB Logo
Develops and markets herbal supplements and natural beauty products on a global scale.
Sweden NNH
NIPPON CHEMIPHAR CO., LTD. Logo Japan 4539
Nippon Shinyaku Co.,Ltd. Logo Japan 4516
Noile-Immune Biotech Inc. Logo Japan 4893
Novacyt Logo
Designs and supplies molecular diagnostic tests and PCR kits for human, veterinary, and food safety.
France ALNOV
Novartis AG Logo
Researches and develops patented and generic medicines for areas of high medical need.
Switzerland NOVN
Novo Nordisk Logo
Develops medicines and devices for chronic diseases like diabetes, obesity, and rare disorders.
Denmark NOVO
NUTEX Investments Plc Logo
Develops & distributes health, cosmetic & pharma products from natural ingredients globally.
Hungary NUTEX
Nxera Pharma Co., Ltd. Logo Japan 4565